National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody E2.3
A murine IgG1 monoclonal antibody directed against the human transferrin (Tf) receptor. Monoclonal antibody E2.3 binds to the Tf receptor, blocking the binding of transferrin to the receptor and resulting in decreased tumor cell growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Anti-Transferrin MOAB E2.3
E2.3
Abbreviation:MOAB E2.3



Previous:monoclonal antibody CAL, monoclonal antibody CC49, monoclonal antibody CC49-delta CH2, monoclonal antibody Ch14.18, monoclonal antibody CHIR-12.12
Next:monoclonal antibody G250, monoclonal antibody GD2 anti-idiotype vaccine, monoclonal antibody hA20, monoclonal antibody HeFi-1, monoclonal antibody hLL1

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov